Research

Hormonal

GLP-1 receptor agonists reduce the formation of atherosclerotic plaques and lower inflammatory markers in patients with type 2 diabetes.

GLP-1 medications may help protect against heart disease by reducing the buildup of plaque in arteries and lowering inflammation, in addition to their weight loss effects.

GoodSupportsMEDIUM confidence
GLP-1 RAs have been shown to reduce the formation of these atherosclerotic plaques and reduce the production of TNF-a and interleukin-1 (IL-1), two proinflammatory cytokines.
Alan D. Kaye et al. · Cureus · 2024

Why this rating

Based on animal studies (mice) showing reduced plaque area.

Source

Glucagon-Like Peptide-1 Receptor Agonist Mediated Weight Loss and Diabetes Mellitus Benefits: A Narrative Review

Alan D. Kaye et al. · Cureus · 2024

DOI 10.7759/cureus.76101

narrative_reviewCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →